Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
5560 items from SEC EDGAR · clear filters
- 8-K - SeeQC, Inc. (0001779977) (Filer)
SeeQC, Inc. filed a Form 8-K on August 28, 2026 reporting the termination of a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - Spero Therapeutics, Inc. (0001701108) (Filer)
Spero Therapeutics filed a Form 8-K on August 28, 2026, reporting entry into a material definitive agreement, other events, and accompanying financial statements and exhibits.
- 8-K - Boundless Bio, Inc. (0001782303) (Filer)
Boundless Bio, Inc. filed a Form 8-K on August 28, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Brand Engagement Network Inc. (0001838163) (Filer)
Brand Engagement Network Inc. filed a Form 8-K on August 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) with an accompanying 256 KB filing.
- 8-K - MOBIX LABS, INC (0001855467) (Filer)
Mobix Labs, Inc. filed a Form 8-K reporting a material definitive agreement, a new direct financial obligation, unregistered equity sales, changes to security holder rights, director/officer departures and appointments with related compensation, and accompanying financial statements.
- 8-K - PILGRIMS PRIDE CORP (0000802481) (Filer)
Pilgrims Pride Corp filed a Form 8-K on August 28, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Constellation Acquisition Corp I (0001834032) (Filer)
Constellation Acquisition Corp I filed a Form 8-K on August 28, 2026, disclosing the creation of a direct financial obligation and/or an off-balance-sheet arrangement as required under Item 2.03.
- 8-K - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Filer)
Intelligent Bio Solutions Inc. filed a Form 8-K on August 28, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - POWERCOMPUTE, INC. (0001640384) (Filer)
PowerCompute, Inc. filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - ALLIANCE ENTERTAINMENT HOLDING CORP (0001823584) (Filer)
Alliance Entertainment Holding Corp filed a Form 8-K reporting amendments to its articles of incorporation and bylaws, a change in fiscal year, and accompanying financial statements and exhibits.
- 8-K - Glucotrack, Inc. (0001506983) (Filer)
Glucotrack, Inc. filed a Form 8-K on August 28, 2026, reporting amendments to its articles of incorporation or bylaws, a change in fiscal year, other events, and accompanying financial statements and exhibits.
- 8-K - RenX Enterprises Corp. (0001959023) (Filer)
RenX Enterprises Corp filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - T1 Energy Inc. (0001992243) (Filer)
T1 Energy Inc. filed an 8-K with the SEC on August 28, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing is accessible under accession number 0001213900-26-095184.
- 8-K - Coherus Oncology, Inc. (0001512762) (Filer)
Coherus Oncology, Inc. filed a Form 8-K with the SEC on August 28, 2026 (Accession No. 0001104659-26-103316), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - AIRWA INC. (0001674440) (Filer)
Airwa Inc. filed a Form 8-K on August 28, 2026, disclosing a notice of delisting or failure to satisfy a continued listing rule, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - LEHMAN ABS CORP GOLDMAN SACHS CAP 1 SEC BACKED SER 2004-6 (0001284143) (Filer)
Lehman ABS Corp filed a Form 8-K on August 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)
Cumberland Pharmaceuticals Inc. filed a Form 8-K on August 28, 2026, providing a Regulation FD Disclosure under Item 7.01.
- 8-K - ORAGENICS INC (0001174940) (Filer)
Oragenics Inc. filed a Form 8-K reporting a notice of delisting and a transfer of its listing, along with other events and accompanying financial statements and exhibits.
- 8-K - TPG Twin Brook Capital Income Fund (0001913724) (Filer)
TPG Twin Brook Capital Income Fund filed a Form 8-K on August 28, 2026, reporting a Regulation FD Disclosure and other events, as disclosed in accession number 0001913724-26-000026.
- 8-K - Sezzle Inc. (0001662991) (Filer)
Sezzle Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) on August 28, 2026, with accession number 0001662991-26-000148.
- 8-K - SOCKET MOBILE, INC. (0000944075) (Filer)
Socket Mobile, Inc. filed a Form 8-K indicating it received a notice of delisting or failure to satisfy a continued listing rule and that its securities will be transferred to a different listing.
- 8-K - SRX Global Inc. (0001471727) (Filer)
SRX Global Inc. filed a Form 8-K on August 28, 2026 reporting entry into a material definitive agreement, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - PEDEVCO CORP (0001141197) (Filer)
PeDevCo Corp filed a Form 8-K reporting the departure and appointment of certain directors and officers, related compensation arrangements, items submitted for shareholder vote, and accompanying financial statements and exhibits.
- 8-K - Sinclair, Inc. (0001971213) (Filer)
Sinclair, Inc. filed an 8-K on August 28, 2026 reporting the departure and appointment of certain directors and officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - Crinetics Pharmaceuticals, Inc. (0001658247) (Filer)
Crinetics Pharmaceuticals filed a Form 8-K on August 28, 2026, reporting a submission of matters to a vote of security holders (Item 5.07) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - NORWOOD FINANCIAL CORP (0001013272) (Filer)
Norwood Financial Corp filed a Form 8-K on August 28, 2026, reporting other events under Item 8.01 and including financial statements and related exhibits under Item 9.01.
- 8-K - BiomX Inc. (0001739174) (Filer)
BiomX Inc. filed a Form 8-K on August 28, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001213900-26-095146.
- 8-K - Andretti Acquisition Corp. II (0002025341) (Filer)
Andretti Acquisition Corp. II filed a Form 8-K reporting entry into a material definitive agreement, submission of matters to a shareholder vote, other events, and accompanying financial statements and exhibits.
- 8-K - IonQ, Inc. (0001824920) (Filer)
IonQ, Inc. filed a Form 8-K reporting departures and appointments of directors and certain officers, related compensatory arrangements, other events, and included its financial statements and accompanying exhibits.
- 8-K - SharonAI Holdings Inc. (0002068385) (Filer)
SharonAI Holdings Inc. filed a Form 8-K reporting the departure, election or appointment of directors and certain officers, related compensatory arrangements, matters submitted for a shareholder vote, and accompanying financial statements and exhibits.